APO RESEARCH · REPORT
Hematopoietic Stem Cells Transplantation
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Product & engineering
Understand the product.
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Selected research
Industry Growth & Trends
Global Hematopoietic Stem Cells Transplantation Industry Growth and Trends Forecast to 2032
Market perspective
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
According to APO Research, the global Hematopoietic Stem Cells Transplantation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Hematopoietic Stem Cells Transplantation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Hematopoietic Stem Cells Transplantation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hematopoietic Stem Cells Transplantation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hematopoietic Stem Cells Transplantation.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Hematopoietic Stem Cells Transplantation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Hematopoietic Stem Cells Transplantation Market by Company
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Hematopoietic Stem Cells Transplantation Segment by Type
Stem Cells Storage
Stem Cells Consumables
Hematopoietic Stem Cells Transplantation Segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
Hematopoietic Stem Cells Transplantation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematopoietic Stem Cells Transplantation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hematopoietic Stem Cells Transplantation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematopoietic Stem Cells Transplantation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Hematopoietic Stem Cells Transplantation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Stem Cells Storage
- Stem Cells Consumables
Applications
- Leukemia
- Lymphoproliferative Disorders
- Solid Tumors
- Non-Malignant Disorders
Companies covered
- CBR Systems
- China Cord Blood Corporation
- ViaCord
- Thermo Fisher Scientific
- STEMCELL Technologies
- Vcanbio
- Merck Millipore
- Lonza Group
- CellGenix Technologie Transfer
- ThermoGenesis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Hematopoietic Stem Cells Transplantation Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Hematopoietic Stem Cells Transplantation Market Size by Region (2021-2032)
- 1.4.1 Global Hematopoietic Stem Cells Transplantation Market Size by Region (2021-2026)
- 1.4.2 Global Hematopoietic Stem Cells Transplantation Market Size by Region (2027-2032)
- 1.5 Key Regions Hematopoietic Stem Cells Transplantation Market Size (2021-2032)
- 1.5.1 North America Hematopoietic Stem Cells Transplantation Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Hematopoietic Stem Cells Transplantation Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size Growth Rate (2021-2032)
- 1.5.4 South America Hematopoietic Stem Cells Transplantation Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size Growth Rate (2021-2032)
2 Hematopoietic Stem Cells Transplantation Market by Type
- 2.1 Type Introduction
- 2.1.1 Stem Cells Storage
- 2.1.2 Stem Cells Consumables
- 2.2 Global Hematopoietic Stem Cells Transplantation Market Size by Type
- 2.2.1 Global Hematopoietic Stem Cells Transplantation Market Size Overview by Type (2021-2032)
- 2.2.2 Global Hematopoietic Stem Cells Transplantation Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Hematopoietic Stem Cells Transplantation Market Size Forecasted by Type (2027-2032)
- 2.3 Global Hematopoietic Stem Cells Transplantation Market Size by Regions
- 2.3.1 North America Hematopoietic Stem Cells Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Hematopoietic Stem Cells Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Hematopoietic Stem Cells Transplantation Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Hematopoietic Stem Cells Transplantation Market Size Breakdown by Type (2021-2026)
3 Hematopoietic Stem Cells Transplantation Market by Application
- 3.1 Type Introduction
- 3.1.1 Leukemia
- 3.1.2 Lymphoproliferative Disorders
- 3.1.3 Solid Tumors
- 3.1.4 Non-Malignant Disorders
- 3.2 Global Hematopoietic Stem Cells Transplantation Market Size by Application
- 3.2.1 Global Hematopoietic Stem Cells Transplantation Market Size Overview by Application (2021-2032)
- 3.2.2 Global Hematopoietic Stem Cells Transplantation Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Hematopoietic Stem Cells Transplantation Market Size Forecasted by Application (2027-2032)
- 3.3 Global Hematopoietic Stem Cells Transplantation Market Size by Regions
- 3.3.1 North America Hematopoietic Stem Cells Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Hematopoietic Stem Cells Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Hematopoietic Stem Cells Transplantation Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Hematopoietic Stem Cells Transplantation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Hematopoietic Stem Cells Transplantation Industry Trends
- 4.2 Hematopoietic Stem Cells Transplantation Industry Drivers
- 4.3 Hematopoietic Stem Cells Transplantation Industry Opportunities and Challenges
- 4.4 Hematopoietic Stem Cells Transplantation Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Hematopoietic Stem Cells Transplantation Revenue (2021-2026)
- 5.2 Global Hematopoietic Stem Cells Transplantation Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Hematopoietic Stem Cells Transplantation Key Company Headquarters & Area Served
- 5.4 Global Hematopoietic Stem Cells Transplantation Company, Product Type & Application
- 5.5 Global Hematopoietic Stem Cells Transplantation Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Hematopoietic Stem Cells Transplantation Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Hematopoietic Stem Cells Transplantation Players Market Share by Revenue in 2025
- 5.6.3 2025 Hematopoietic Stem Cells Transplantation Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 CBR Systems
- 6.1.1 CBR Systems Company Information
- 6.1.2 CBR Systems Business Overview
- 6.1.3 CBR Systems Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 CBR Systems Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.1.5 CBR Systems Recent Developments
- 6.2 China Cord Blood Corporation
- 6.2.1 China Cord Blood Corporation Company Information
- 6.2.2 China Cord Blood Corporation Business Overview
- 6.2.3 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 China Cord Blood Corporation Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.2.5 China Cord Blood Corporation Recent Developments
- 6.3 ViaCord
- 6.3.1 ViaCord Company Information
- 6.3.2 ViaCord Business Overview
- 6.3.3 ViaCord Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ViaCord Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.3.5 ViaCord Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 STEMCELL Technologies
- 6.5.1 STEMCELL Technologies Company Information
- 6.5.2 STEMCELL Technologies Business Overview
- 6.5.3 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 STEMCELL Technologies Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.5.5 STEMCELL Technologies Recent Developments
- 6.6 Vcanbio
- 6.6.1 Vcanbio Company Information
- 6.6.2 Vcanbio Business Overview
- 6.6.3 Vcanbio Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Vcanbio Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.6.5 Vcanbio Recent Developments
- 6.7 Merck Millipore
- 6.7.1 Merck Millipore Company Information
- 6.7.2 Merck Millipore Business Overview
- 6.7.3 Merck Millipore Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Merck Millipore Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.7.5 Merck Millipore Recent Developments
- 6.8 Lonza Group
- 6.8.1 Lonza Group Company Information
- 6.8.2 Lonza Group Business Overview
- 6.8.3 Lonza Group Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Lonza Group Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.8.5 Lonza Group Recent Developments
- 6.9 CellGenix Technologie Transfer
- 6.9.1 CellGenix Technologie Transfer Company Information
- 6.9.2 CellGenix Technologie Transfer Business Overview
- 6.9.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.9.5 CellGenix Technologie Transfer Recent Developments
- 6.10 ThermoGenesis
- 6.10.1 ThermoGenesis Company Information
- 6.10.2 ThermoGenesis Business Overview
- 6.10.3 ThermoGenesis Hematopoietic Stem Cells Transplantation Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ThermoGenesis Hematopoietic Stem Cells Transplantation Product Portfolio
- 6.10.5 ThermoGenesis Recent Developments
7 North America
- 7.1 North America Hematopoietic Stem Cells Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 7.3 North America Hematopoietic Stem Cells Transplantation Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Hematopoietic Stem Cells Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 8.3 Europe Hematopoietic Stem Cells Transplantation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Hematopoietic Stem Cells Transplantation Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Hematopoietic Stem Cells Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 10.3 South America Hematopoietic Stem Cells Transplantation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Hematopoietic Stem Cells Transplantation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst